advertisement
Polo V 19
Showing records 1 to 19 | Display all abstracts from Polo V91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Rodrigo MJ
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Rodrigo MJ
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Rodrigo MJ
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Rodrigo MJ; Martinez-Rincon T
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Cardiel MJ
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Martinez-Rincon T; Subias M
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Fraile JM
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Subias M
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Mendez-Martinez S
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Mendez-Martinez S; Mendez-Martinez S
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Mendez-Martinez S
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Luna C
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Martinez-Rincon T; Martinez-Rincon T; Subias M
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Pablo LE
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Subias M
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Polo V
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Polo V
Biomaterials science 2020; 8: 6246-6260
91026 Effect of age and sex on neurodevelopment and neurodegeneration in the healthy eye: Longitudinal functional and structural study in the Long-Evans rat
Garcia-Martin E
Experimental Eye Research 2020; 200: 108208
91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Ruberte J; Ramirez T; Vispe E; Luna C; Mayoral JA; Garcia-Martin E
Biomaterials science 2020; 8: 6246-6260